Kurt Waldeland

Founded in 2001, Macquarie Capital (USA), Inc. is a registered broker/dealer located in New York City. The firm is a subsidiary of Macquarie Bank Ltd. (ASX: MBL). They provide coverage of the following industries: resources, healthcare, security/defense, transportation, financial services, retail/consumer products, TMET (telecommunications, media, entertainment and technology), oil & gas, diversified manufacturing/distribution and infrastructure/utilities. Macquarie Capital (USA), Inc. is a member of FINRA.

Fondsfinans Kapitalforvaltning ASA (FK) is the wholly-owned asset management subsidiary of Erik Must AS in Norway. Headquartered in Oslo, FK provides discretionary asset management services and manages a range of mutual funds. The firm was founded in 1997.

DNB Bank ASA is a brokerage division of DNB ASA (OTCMKTS: DNHBY), a financial services group headquartered in Oslo, Norway. Founded in 1822, DNB Bank provides full service execution services to institutional and corporates clients.

Cubera Private Equity AS is a Private Equity firm, a subsidiary of Storebrand Asset Management AS founded in 2006 by Kine Burøy Olsen and Jørgen Kjærnes. Cubera Private Equity AS is headquartered in Oslo with additional office in Stockholm.

Eika Kapitalforvaltning AS (Eika) is the fund management subsidiary of Eika Gruppen AS in Norway. Formerly known as Terra Forvaltning AS, the firm was created in 2008 as a result of the merger of Terra Fondsforvaltning and WarrenWicklund Fondsforvaltning. The firm is based in Oslo and manages mutual funds previously managed by Terra Fondsforvaltning and WarrenWicklund Fondsforvaltning.

Part of T.D. Veen AS, P53 Invest AS provides investment services for the healthcare industry. The company is based in Oslo, Norway. Susanne Stuffers has been the CEO of the Norwegian company since 2018.

Jordanes AS provides investment and business development services. It invested in commercial activities. The company was founded on January 16, 2018 and is headquartered in Oslo, Norway.

Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022.